1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Eye Drops Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Eye Drops Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising cases of cataract diseases and technological developments
- 5.1.2 Rising Number of Glaucoma globally
5.2 Market Opportunities
- 5.2.1 Innovative Product Launches
5.4 Impact of Drivers and Restraints
6. North America Eye Drops Market Regional Analysis
6.1 North America Eye Drops Market Overview
6.2 North America Eye Drops Market Revenue 2020-2030 (US$ Million)
6.3 North America Eye Drops Market Forecast Analysis
7. North America Eye Drops Market Analysis – by Type
7.1 Antibiotics
- 7.1.1 Overview
- 7.1.2 Antibiotics: North America Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Artificial Tears
- 7.2.1 Overview
- 7.2.2 Artificial Tears: North America Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Hormones
- 7.3.1 Overview
- 7.3.2 Hormones: North America Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Eye Drops Market Analysis – by Application
8.1 Eye Diseases
- 8.1.1 Overview
- 8.1.2 Eye Diseases: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Eye Care
- 8.2.1 Overview
- 8.2.2 Eye Care: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Eye Drops Market Analysis – by Purchase Mode
9.1 OTC
- 9.1.1 Overview
- 9.1.2 Eye Care: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Prescription
- 9.2.1 Overview
- 9.2.2 Eye Care: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Eye Drops Market – North America Analysis
10.1 North America
- 10.1.1 North America Eye Drops Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 North America Eye Drops Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 US: North America Eye Drops Market Breakdown, by Type
- 10.1.1.1.2 US: North America Eye Drops Market Breakdown, by Application
- 10.1.1.1.3 US: North America Eye Drops Market Breakdown, by Purchase Mode
- 10.1.1.2 Canada:
North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Canada: North America Eye Drops Market Breakdown, by Type
- 10.1.1.2.2 Canada: North America Eye Drops Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Eye Drops Market Breakdown, by Purchase Mode
- 10.1.1.3 Mexico :
North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Mexico : North America Eye Drops Market Breakdown, by Type
- 10.1.1.3.2 Mexico : North America Eye Drops Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Eye Drops Market Breakdown, by Purchase Mode
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Eye Drops Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 AbbVie Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Akorn Operating Company LLC
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Alcon AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bausch & Lomb Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Pfizer Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Prestige Consumer Healthcare Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Rohto Pharmaceutical Co Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Similasan Corp
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Eye Drops Market
